Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Folium-artemisiae-argyi-containing medicinal preparation for treating polycystic ovarian syndrome and preparation method thereof

A pharmaceutical preparation and polycystic ovary technology, applied in the field of traditional Chinese medicine, can solve the problems that the curative effect needs to be further strengthened, the effect varies greatly among individuals, and the treatment cycle of polycystic ovary syndrome is long. Promoted app performance

Inactive Publication Date: 2016-07-13
GUANGZHOU JINAN BIOMEDICINE RES & DEV CENT
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The drug has the functions of activating blood circulation and removing blood stasis, regulating qi and promoting stagnation, etc. However, the treatment cycle for polycystic ovary syndrome is long, and the effect varies greatly among individuals, so the curative effect needs to be further strengthened

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] The Chinese medicine prescription of the Chinese medicine preparation in Example 1 of the present invention includes the following preparation raw materials in parts by weight: 23 parts of Artemisia argyi, 25 parts of Gentiana, 26 parts of Scutellaria baicalensis, 18 parts of Digupi, 14 parts of Akebia, 18 parts of Motherwort, Sichuan Neem 15 parts, Eupatorium 12 parts, gardenia 10 parts, peach kernel 11 parts, cinnamon 12 parts, scutellaria baicalensis 9 parts and licorice 14 parts.

[0038] Preparation:

[0039] Step (1), take by weighing each Chinese herbal medicine according to the Chinese medicine prescription of the present invention;

[0040] Step (2), pulverize Artemisia argyi, Gentiana, Scutellaria baicalensis, Digupi and Akebia respectively, add 75% ethanol at a concentration of 10 times the weight of medicinal materials after mixing, soak for 6 hours, extract twice, each time for 3 hours , filter and retain the filter residue, combine the filtrates, remove e...

Embodiment 2

[0044] The Chinese medicine prescription of the Chinese medicine preparation of Example 2 of the present invention includes the following preparation raw materials in parts by weight: 15 parts of Artemisia argyi, 18 parts of Gentiana, 20 parts of Scutellaria baicalensis, 13 parts of Digupi, 10 parts of Akebia, 13 parts of Motherwort, Sichuan 10 parts of Neem, 8 parts of Eupatorium, 6 parts of Gardenia, 7 parts of peach kernel, 7 parts of cinnamon, 5 parts of skullcap and 8 parts of licorice;

[0045] The preparation method is the same as in Example 1.

Embodiment 3

[0047] The Chinese medicine composition of the Chinese medicine preparation in Example 1 of the present invention includes the following preparation raw materials in parts by weight: 7 parts of Artemisia argyi, 11 parts of Gentiana, 14 parts of Scutellaria baicalensis, 8 parts of Digupi, 6 parts of Akebia, 8 parts of Motherwort, Sichuan Neem 5 parts, Eupatorium 4 parts, Gardenia 2 parts, Peach kernel 3 parts, Cinnamon 1 part, Scutellaria baicalensis 1 part and Licorice 2 parts;

[0048] The preparation method is the same as in Example 1.

[0049] Animal efficacy test of pharmaceutical preparation of the present invention

[0050] 1. Experimental drug

[0051] The capsules prepared in Examples 1-3 of the present invention have a crude drug content equivalent to 1.05 g of crude drug / capsule, the capsule shell is removed, and distilled water is added to prepare a solution. Ethinylestradiol Cyproterone Tablets (Guoyao Zhunzi J20140114, Schering GmbH & Co. ProduktionsKG), 2mg cyp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a folium-artemisiae-argyi-containing medicinal preparation for treating polycystic ovarian syndrome and a preparation method thereof.The medicinal preparation is prepared from 13 types of traditional Chinese medicinal materials, namely folium artemisiae argyi, radix gentianae, radix scutellariae, cortex lycii radicis, akebia stems, herba leonuri, szechwan Chinaberry fruits, hiraute shiny bugleweek herbs, fructus gardeniae, peach kernels, cortex cinnamomi, radix scutellariae and liquorice roots.When being used for treating polycystic ovarian syndrome, the medicinal preparation has the technical advantages that effectiveness is achieved fast, the effect is good, both symptoms and root causes of the disease are treated, regulation and treatment are combined, the disease is not prone to relapse; in addition, the preparation process is simple, convenient and easy to implement, and the preparation is stable in medicinal effect, good in universality and easy to apply and popularize.

Description

technical field [0001] The invention relates to a medicinal preparation containing mugwort leaves for treating polycystic ovary syndrome and a preparation method thereof, belonging to the field of traditional Chinese medicines. technical background [0002] Polycystic ovary syndrome is a syndrome clinically characterized by chronic anovulation, amenorrhea or oligomenorrhea, infertility, obesity, hirsutism, polycystic ovarian enlargement, hyperandrogenemia, and insulin resistance. Polycystic ovary syndrome is the end-stage ovarian pathological change of the disease caused by endocrine axis dysfunction. [0003] At present, the Western medicine treatment of polycystic ovary syndrome mainly adopts different measures according to different ages and different situations: for adolescent patients, it should be mainly to regulate nerves, endocrine, metabolism or anti-androgen hyperactivity, and the ovulation-inducing drug clomiphene should not be used; Patients who want to bear chi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/815A61P15/08
CPCA61K36/815A61K36/185A61K36/282A61K36/484A61K36/515A61K36/53A61K36/533A61K36/539A61K36/54A61K36/58A61K36/736A61K36/744A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 王一飞李风廖晓凤任哲
Owner GUANGZHOU JINAN BIOMEDICINE RES & DEV CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products